Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
Eli Lilly and Company
Age
18–76
Sex
ALL
Healthy volunteers
Not accepted
You may be eligible if
Patients must have schizophrenia or schizoaffective disorders.
Each patient must have a level of understanding sufficient to complete all tests and examinations required by the protocol, and to provide informed consent.
Patient must not have participated in a clinical trial of another investigational drug, including olanzapine, within 1 month (30 days) prior to study entry.
Female patients must not be pregnant or breast-feeding.
Patients must not be experiencing acute, serious, or unstable medical conditions other than schizophrenia or schizoaffective disorder.
Clareo Health | Pharmacokinetic Characterization of Intramuscular Olanzapine Depot
